Post-approval studies (Phase 4)Ended earlyNCT03224923
What this trial is testing
A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)
Who this might be right for
Stable Coronary SyndromePercutaneous Coronary InterventionAntiplatelet Therapy+1 more
Ottawa Heart Institute Research Corporation 5